Skip to main content

Table 1 The association between SLC2A3 mRNA levels and the clinicopathological parameters in 44 GC patients included in the OS analysis

From: SLC2A3 promotes macrophage infiltration by glycolysis reprogramming in gastric cancer

Clinicopathological parameters SLC2A3 expression p-value
Low High
Age
 < 60 8 13 p = 0.533
 ≥ 60 8 15  
Gender
 Male 12 18 p = 0.350
 Female 4 10  
pStage
 I 5 2 p = 0.049
 II–IV 11 26  
pT grade
 T1, 2 7 4 p = 0.037
 T3, 4 9 24  
pN grade
 N0 9 10 p = 0.157
 N1–3 7 18  
pM grade
 M0 16 26 p = 0.400
 M1 0 2  
Total 16 28  
  1. SLC2A3 protein expression was significantly higher in patients with pathological stage (p = 0.049) and advanced T (p = 0.037) but showed no association with age, gender, N and M grades
  2. GC Gastric cancer, OS overall survival, TNM tumor, N lymph node, M metastasis